Tapentadol is partly metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicines that enrich or repress the exercise/expression of a number of of such enzymes, as well as with substrates of those enzymes (as a consequence of Competitors to the enzyme); some enzyme https://klausp219abh2.bmswiki.com/user